Sunmax Biotechnology Co Ltd (4728) — Cash Flow Reinvestment Rate
Sunmax Biotechnology Co Ltd (4728) has a Cash Flow Reinvestment Rate of 1.35x as of September 2025, reinvesting NT$217.44 Million (capex NT$17.44 Million plus investments NT$-200.00 Million) from operating cash flow of NT$160.84 Million. See 4728 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Sunmax Biotechnology Co Ltd Cash Flow Reinvestment Rate (2016–2024)
Historical reinvestment intensity for Sunmax Biotechnology Co Ltd across 9 annual periods. For the full cash flow conversion analysis, see 4728 cash generation efficiency.
Annual Cash Flow Reinvestment Rate for Sunmax Biotechnology Co Ltd (2016–2024)
Year-by-year capital reinvestment analysis for Sunmax Biotechnology Co Ltd. See 4728 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.14x | NT$53.71 Million | NT$397.37 Million | NT$36.61 Million | ▼ -9.3% |
| 2023 | 0.15x | NT$126.43 Million | NT$848.56 Million | NT$110.39 Million | ▼ -86.3% |
| 2022 | 1.09x | NT$372.50 Million | NT$342.97 Million | NT$152.03 Million | ▼ -10.5% |
| 2021 | 1.21x | NT$295.11 Million | NT$243.28 Million | NT$255.43 Million | ▲ +195.3% |
| 2020 | 0.41x | NT$158.97 Million | NT$386.97 Million | NT$130.10 Million | ▲ +2.5% |
| 2019 | 0.40x | NT$116.05 Million | NT$289.51 Million | NT$13.68 Million | ▼ -56.3% |
| 2018 | 0.92x | NT$92.50 Million | NT$100.83 Million | NT$4.72 Million | ▼ -72.0% |
| 2017 | 3.28x | NT$121.50 Million | NT$37.09 Million | NT$3.15 Million | ▲ +514.9% |
| 2016 | 0.53x | NT$8.83 Million | NT$16.58 Million | NT$4.73 Million | — |